Selected research
Market Structure
Global Probiotic Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Probiotic Infant Formula market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Probiotic Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Probiotic Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Probiotic Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Probiotic Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Probiotic Infant Formula include Enfamil, Envivo, Nestlé Health Science, New Beginnings Nutritionals, Bellamy's Organic, HiPP, Custom Probiotics Inc., SFl Health and Similac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Probiotic Infant Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Probiotic Infant Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Probiotic Infant Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Probiotic Infant Formula market size, projected growth trends, production technologies, key applications, and end-use industries.
Probiotic Infant Formula Segment by Company
Enfamil
Envivo
Nestlé Health Science
New Beginnings Nutritionals
Bellamy's Organic
HiPP
Custom Probiotics Inc.
SFl Health
Similac
Nutricia Neocate
Probiotic Infant Formula Segment by Type
Premature
Infant
Toddler
Probiotic Infant Formula Segment by Application
Supermarket
Specialty Store
Online Sales
Other
Probiotic Infant Formula Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotic Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Probiotic Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotic Infant Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Probiotic Infant Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Probiotic Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Probiotic Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Probiotic Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Premature
- Infant
- Toddler
Applications
- Supermarket
- Specialty Store
- Online Sales
- Other
Companies covered
- Enfamil
- Envivo
- Nestlé Health Science
- New Beginnings Nutritionals
- Bellamy's Organic
- HiPP
- Custom Probiotics Inc.
- SFl Health
- Similac
- Nutricia Neocate
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Probiotic Infant Formula Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Probiotic Infant Formula Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Probiotic Infant Formula Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Probiotic Infant Formula Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Probiotic Infant Formula Market Dynamics
- 2.1 Probiotic Infant Formula Industry Trends
- 2.2 Probiotic Infant Formula Industry Drivers
- 2.3 Probiotic Infant Formula Industry Opportunities and Challenges
- 2.4 Probiotic Infant Formula Industry Restraints
3 Probiotic Infant Formula Market by Manufacturers
- 3.1 Global Probiotic Infant Formula Revenue by Manufacturers (2021-2026)
- 3.2 Global Probiotic Infant Formula Sales by Manufacturers (2021-2026)
- 3.3 Global Probiotic Infant Formula Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Probiotic Infant Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Probiotic Infant Formula Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Probiotic Infant Formula Manufacturers, Product Type & Application
- 3.7 Global Probiotic Infant Formula Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Probiotic Infant Formula Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Probiotic Infant Formula Players Market Share by Revenue in 2025
- 3.8.3 2025 Probiotic Infant Formula Tier 1, Tier 2, and Tier 3
4 Probiotic Infant Formula Market by Type
- 4.1 Probiotic Infant Formula Type Introduction
- 4.1.1 Premature
- 4.1.2 Infant
- 4.1.3 Toddler
- 4.2 Global Probiotic Infant Formula Sales by Type
- 4.2.1 Global Probiotic Infant Formula Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Probiotic Infant Formula Sales by Type (2021-2032)
- 4.2.3 Global Probiotic Infant Formula Sales Market Share by Type (2021-2032)
- 4.3 Global Probiotic Infant Formula Revenue by Type
- 4.3.1 Global Probiotic Infant Formula Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Probiotic Infant Formula Revenue by Type (2021-2032)
- 4.3.3 Global Probiotic Infant Formula Revenue Market Share by Type (2021-2032)
5 Probiotic Infant Formula Market by Application
- 5.1 Probiotic Infant Formula Application Introduction
- 5.1.1 Supermarket
- 5.1.2 Specialty Store
- 5.1.3 Online Sales
- 5.1.4 Other
- 5.2 Global Probiotic Infant Formula Sales by Application
- 5.2.1 Global Probiotic Infant Formula Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Probiotic Infant Formula Sales by Application (2021-2032)
- 5.2.3 Global Probiotic Infant Formula Sales Market Share by Application (2021-2032)
- 5.3 Global Probiotic Infant Formula Revenue by Application
- 5.3.1 Global Probiotic Infant Formula Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Probiotic Infant Formula Revenue by Application (2021-2032)
- 5.3.3 Global Probiotic Infant Formula Revenue Market Share by Application (2021-2032)
6 Global Probiotic Infant Formula Sales by Region
- 6.1 Global Probiotic Infant Formula Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Probiotic Infant Formula Sales by Region (2021-2032)
- 6.2.1 Global Probiotic Infant Formula Sales by Region (2021-2026)
- 6.2.2 Global Probiotic Infant Formula Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Probiotic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Probiotic Infant Formula Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Probiotic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Probiotic Infant Formula Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Probiotic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Probiotic Infant Formula Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Probiotic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Probiotic Infant Formula Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Probiotic Infant Formula Revenue by Region
- 7.1 Global Probiotic Infant Formula Revenue by Region
- 7.1.1 Global Probiotic Infant Formula Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Probiotic Infant Formula Revenue by Region (2021-2026)
- 7.1.3 Global Probiotic Infant Formula Revenue by Region (2027-2032)
- 7.1.4 Global Probiotic Infant Formula Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Probiotic Infant Formula Revenue (2021-2032)
- 7.2.2 North America Probiotic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Probiotic Infant Formula Revenue (2021-2032)
- 7.3.2 Europe Probiotic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Probiotic Infant Formula Revenue (2021-2032)
- 7.4.2 Asia-Pacific Probiotic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Probiotic Infant Formula Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Probiotic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Enfamil
- 8.1.1 Enfamil Company Information
- 8.1.2 Enfamil Business Overview
- 8.1.3 Enfamil Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Enfamil Probiotic Infant Formula Product Portfolio
- 8.1.5 Enfamil Recent Developments
- 8.2 Envivo
- 8.2.1 Envivo Company Information
- 8.2.2 Envivo Business Overview
- 8.2.3 Envivo Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Envivo Probiotic Infant Formula Product Portfolio
- 8.2.5 Envivo Recent Developments
- 8.3 Nestlé Health Science
- 8.3.1 Nestlé Health Science Company Information
- 8.3.2 Nestlé Health Science Business Overview
- 8.3.3 Nestlé Health Science Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Nestlé Health Science Probiotic Infant Formula Product Portfolio
- 8.3.5 Nestlé Health Science Recent Developments
- 8.4 New Beginnings Nutritionals
- 8.4.1 New Beginnings Nutritionals Company Information
- 8.4.2 New Beginnings Nutritionals Business Overview
- 8.4.3 New Beginnings Nutritionals Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 New Beginnings Nutritionals Probiotic Infant Formula Product Portfolio
- 8.4.5 New Beginnings Nutritionals Recent Developments
- 8.5 Bellamy's Organic
- 8.5.1 Bellamy's Organic Company Information
- 8.5.2 Bellamy's Organic Business Overview
- 8.5.3 Bellamy's Organic Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Bellamy's Organic Probiotic Infant Formula Product Portfolio
- 8.5.5 Bellamy's Organic Recent Developments
- 8.6 HiPP
- 8.6.1 HiPP Company Information
- 8.6.2 HiPP Business Overview
- 8.6.3 HiPP Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 HiPP Probiotic Infant Formula Product Portfolio
- 8.6.5 HiPP Recent Developments
- 8.7 Custom Probiotics Inc.
- 8.7.1 Custom Probiotics Inc. Company Information
- 8.7.2 Custom Probiotics Inc. Business Overview
- 8.7.3 Custom Probiotics Inc. Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Custom Probiotics Inc. Probiotic Infant Formula Product Portfolio
- 8.7.5 Custom Probiotics Inc. Recent Developments
- 8.8 SFl Health
- 8.8.1 SFl Health Company Information
- 8.8.2 SFl Health Business Overview
- 8.8.3 SFl Health Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 SFl Health Probiotic Infant Formula Product Portfolio
- 8.8.5 SFl Health Recent Developments
- 8.9 Similac
- 8.9.1 Similac Company Information
- 8.9.2 Similac Business Overview
- 8.9.3 Similac Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Similac Probiotic Infant Formula Product Portfolio
- 8.9.5 Similac Recent Developments
- 8.10 Nutricia Neocate
- 8.10.1 Nutricia Neocate Company Information
- 8.10.2 Nutricia Neocate Business Overview
- 8.10.3 Nutricia Neocate Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Nutricia Neocate Probiotic Infant Formula Product Portfolio
- 8.10.5 Nutricia Neocate Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Probiotic Infant Formula Value Chain Analysis
- 9.1.1 Probiotic Infant Formula Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Probiotic Infant Formula Production Mode & Process
- 9.2 Probiotic Infant Formula Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Probiotic Infant Formula Distributors
- 9.2.3 Probiotic Infant Formula Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst